Evgeniya E. Feygina

Characterization of endogenously circulating IGFBP-4 fragments—Novel biomarkers for cardiac risk assessment

Alexey A. Konev, T. I. Smolyanova, Alexey V. Kharitonov et al. · Clinical Biochemistry · 2015 · 23 citations · Full text

Life Sciences, Biochemistry, Cardiology +16

Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays

Alexander G Semenov, Natalia N Tamm, Fred S. Apple et al. · Clinical Biochemistry · 2016 · 18 citations · Full text

Medicine, Biochemistry, Cardiology +16

Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP

Ling Li, Alexander G Semenov, Evgeniya E. Feygina et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2022 · 14 citations · Full text

Medicine, Cardiology, Internal Medicine +8

Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure

Evgeniya E. Feygina, M. Artemieva, Alexander B. Postnikov et al. · Clinical Chemistry · 2019 · 12 citations · Full text

Medicine, Cardiology, Pharmacology +13